University of California San Francisco
The National Institutes of Health (NIH) on September 30 announced 52 highly competitive awards for high-risk, high-payoff research for young biomedical scientists, and UCSF tops California institutions with four recipients.
UCSF will provide free flu shots to all employees, students and volunteers with UCSF identification at drop-in clinics from Monday, Oct. 4 to Monday, Nov. 1, 2010.
Sally Rankin, who completed her PhD in nursing in 1988 and joined the faculty, has been named interim dean of the UCSF School of Nursing.
Award-winning scientist David Julius picked up the prestigious Shaw Prize in Hong Kong, where he presented a lecture titled “From Peppers to Peppermints: Natural Products as Probes of the Pain Pathway.”
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
UCSF employees who missed the live webcast of the town hall meeting to discuss the future of UC benefits, can now view the video online.
The UCSF Diabetes Center symposium marks its 10th anniversary.
UCSF research-doctorate programs have ranked among the nation’s best in a survey released today by the National Research Council (NRC).
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
The UCSF School of Medicine is ranked No. 1 for the percentage of Hispanic graduate students attending the top-ranked medical school, according to <cite>Hispanic Business</cite> magazine.
Researchers at UCSF have been awarded a grant from the National Institutes of Health to develop a rapid, pan-viral microarray diagnostic for detecting viruses of extreme outbreak and pandemic potential.
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
Genentech scientist Napoleone Ferrara, who has just been named the winner of a Lasker Award, is being recognized for his noteworthy achievements made when he was a postdoc at UCSF.
Renown Institute for Cancer in Reno and the UCSF Helen Diller Family Comprehensive Cancer Center, the two leading cancer programs in their regions, have joined forces to enhance patient care and improve access to top level medical experts.
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
The U.S. Department of Justice declined to consent to the University of California’s motion to intervene in Sherley v. Sebelius, the case regarding federal funding for human embryonic stem cell (hESC) research, on which UC had made a motion to the U.S. Federal Court of Appeals on Sept. 20.
The UCSF Diabetes Center will celebrate a decade of advancing research and patient care in diabetes with a scientific symposium featuring the nation’s leaders in the field.
The UCSF Diabetes Center will celebrate a decade of advancing translational research in diabetes on Friday, with a scientific symposium featuring the nation’s leaders in diabetes research and care.
The UCSF community is invited to “Art for AIDS,” a benefit featuring the cast of <cite>Dreamgirls</cite>, who will perform songs from that Tony Award-winning musical on September 24.
The UCSF community is invited to learn tips for safety and security at safety fairs scheduled for today and October 13.
Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment – an emerging field of research that could revolutionize medicine by creating “smart cells” to deliver medications and other therapeutics more effectively.
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.
Cancer and infertility can be a double blow. Many women become infertile following cancer treatment. And because more women are living longer thanks to modern chemotherapy and radiation treatment, more are later discovering that they cannot bear children.
UC leaders will host an online town hall meeting on September 24 to talk with faculty, staff and retirees about post-employment benefits, health care costs, UC’s budget and other University issues.
The University of California filed a motion Sept. 20 with the U.S. Federal Court of Appeals to intervene in Sherley v. Sebelius, the case regarding whether federal funds could be used for human embryonic stem cell (hESC) research. UC is the nation’s first research institution to formally seek to intervene in the pending lawsuit.
UCSF students are benefitting from the wisdom of some of the nation’s leading medical educators in shaping their training to be more relevant for the ever-evolving landscape.